Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?
Search

October 2012

More IVD Consolidation as Danaher Acquires Iris

Clinical Laboratory Trends /

CEO SUMMARY: Danaher Corporation continues to fuel growth by continually acquiring in vitro diagnostics (IVD) companies. Its latest purchase is Iris International, which manufactures automated urine microscopy systems. Danaher also has $5 billion available that it could spend in the next two years on acquisitions. Because of its acquisitions over the past decade, Danaher now […]

To access this post, you must purchase The Dark Report.

More IVD Consolidation as Danaher Acquires Iris Read More »

CDC Surveys Docs’ Use of Laboratory Test Results

Clinical Laboratory Trends /

CEO SUMMARY: There’s a treasure trove of information and insights about how physicians use clinical laboratory tests contained in survey data recently collected by a team from the Centers for Disease Control and Prevention. Designed to identify challenges in how physicians utilize laboratory tests, the survey findings offer a road map about how innovative clinical

To access this post, you must purchase The Dark Report.

CDC Surveys Docs’ Use of Laboratory Test Results Read More »

Unprecedented Growth Rates for Molecular Testing

Molecular Diagnostics /

CEO SUMMARY: There will be an expanding role for innovative clinical labs as healthcare moves forward on its path toward personalized medicine. However, to capitalize on this opportunity, pathology groups and clinical labs will need to beef up their information systems. They will also need to recruit lab staff who are skilled in interpreting molecular

To access this post, you must purchase The Dark Report.

Unprecedented Growth Rates for Molecular Testing Read More »

Ampersand Buys Calloway Labs, Enters Pain Management Market

Clinical Laboratory /

URINE DRUG TESTING for pain management may be a challenging business for clinical labs given that compliance officers in the states and in the federal government have successfully pursued lab compliance abuses in this line of business in recent years. Now comes news that private equity firm Ampersand Capital Partners of Wellesley, Massachusetts, is to

To access this post, you must purchase The Dark Report.

Ampersand Buys Calloway Labs, Enters Pain Management Market Read More »

October 8, 2012 “Intelligence: Late Breaking Lab News”

Late Breaking Lab News /

Definiens AG, one of the major players in the fast-growing market for digital pathology, raised $12.8 million in additional capital funding. The company, based in Munich, Germany, manufacturers systems for digital image analysis. Definiens stated that the new funds will be used for “commercial expansion of its current business and to develop and commercialize innovative

To access this post, you must purchase The Dark Report.

October 8, 2012 “Intelligence: Late Breaking Lab News” Read More »

Facebook-f Twitter Linkedin-in

The Dark Report
1000 N West Street, Suite 1200 Wilmington, Delaware, United States, 19801
Phone: 512-264-7103
Email: info@darkreport.com

© 2025 The Dark Report. All rights reserved. Part of the LabX Media Group

;